Which laboratory tests should be ordered for a patient with suspected rheumatoid arthritis?

Laboratory Testing for Suspected Rheumatoid Arthritis

For any patient with suspected rheumatoid arthritis presenting with synovitis, order rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA/anti-CCP), and C-reactive protein (CRP) or erythrocyte sedimentation rate (ESR) as your initial laboratory panel. 1, 2

Core Laboratory Tests

The essential workup includes:

• Rheumatoid Factor (RF): Should be tested in all patients with synovitis 1. RF has moderate sensitivity (60-80%) and specificity (70%) for RA 2

• Anti-Citrullinated Protein Antibodies (ACPA/anti-CCP): This is the most specific test for RA with 90% specificity and 60% sensitivity 2. Consider ACPA testing particularly if RF is negative, as this combination improves diagnostic accuracy 1

• Acute Phase Reactants: Measure either CRP or ESR, but not both—they provide no additional value when ordered together 2. CRP is preferred over ESR because it is more reliable, simpler to perform, and not age-dependent 2

Additional Baseline Laboratory Tests

Beyond the diagnostic serologies, obtain:

• Complete blood count (CBC) with differential 3, 4
• Liver transaminases (AST/ALT) 3
• Renal function tests (creatinine) 3
• Urinalysis 3

These baseline tests are essential for monitoring disease activity and assessing safety before initiating disease-modifying therapy.

Understanding the 2010 ACR/EULAR Classification Criteria

The diagnosis integrates laboratory findings with clinical features in a scoring system 2:

Serologic scoring:

• Negative RF and negative ACPA = 0 points
• Low positive RF or low positive ACPA = 2 points
• High positive RF or high positive ACPA = 3 points

Acute phase reactant scoring:

• Normal CRP and normal ESR = 0 points
• Abnormal CRP or abnormal ESR = 1 point

A total score ≥6/10 across all categories (joint involvement, serology, acute phase reactants, symptom duration) confirms RA classification 2.

Critical Clinical Caveats

Do not delay referral or treatment based on negative laboratory tests. Approximately one-third of RA patients are seronegative (negative RF and ACPA), and more than 40% have normal ESR or CRP at presentation 5. The NICE guidelines explicitly state to refer urgently even with normal acute-phase response or negative RF if clinical synovitis is present 1.

Avoid ordering broad "rheumatology panels" without specific clinical indication, as this increases false-positive results and leads to unnecessary anxiety, further testing, and inappropriate treatment 6, 7. Tests like ANA, HLA-B27, or other autoantibodies should only be ordered when the clinical presentation suggests alternative diagnoses.

Timing and Interpretation

For patients with early-morning stiffness, swollen joints (particularly small joints), and strongly positive ACPA results present for ≥6 weeks (or less if CRP is abnormal), the criteria for RA are fulfilled and disease-modifying therapy should be initiated immediately 2. The presence of clinical synovitis on examination is more important than any laboratory value 3, 6.

Remember that positive RF or ACPA can occur in healthy individuals without RA (false positives), while negative results do not exclude the diagnosis (false negatives) 5, 6. Laboratory tests must always be interpreted within the clinical context of the patient's history and physical examination findings.